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 Nepal has one of the highest snakebite fatalities in South Asia. Most bites 
occur in rural areas where there is a lack of both adequate facilities for 
treatment and transport. Despite several limitations, prompt access and 
focus on supportive care are the major strengths of peripheral healthcare 
centers. Here we present the management of two cases of neurotoxic 
snakebites. Timely intervention can save lives in case of snakebites; 
hence establishment of snakebite treatment centers in the periphery can 
mitigate the problem of delay in care. Patan Academy of Health Sciences 
can contribute by training medical graduates in snakebite management. 
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Patan Academy of Health Sciences (PAHS) 
aims to improve rural health by training 
competent, caring, and socially responsible 
physicians. Every year, PAHS sends out 40% of 
graduates to serve the rural community, 
including lowlands terai in southern Nepal, 
where snakebite is a major problem.1  
 
Here we share the experience of a PAHS 
graduate posted at Beltar Primary Healthcare 
Center (Beltar PHC) in Udayapur District of 
Nepal. Snakebite is among the five topmost 
prioritized hazards in Udayapur.2  
 
Following the transition to local governance, a 
snakebite treatment center was established at 
the PHC in coordination with Nepal Army. 
Within two years of establishment, a total of 
223 cases of bites were received which 
included envenomation, suspected bites, and 
insect bites, minimizing the need to transfer 
these patients to higher healthcare centers. 
 
We present two cases of neurotoxic 
snakebites with different presentations, 
progression, and complications managed at a 





A 9-Year-old with cobra bite 
A 9-year-old male was brought by his mother 
with the chief complaint of severe pain 
following an unknown bite on the right leg 
while leaning against a wall in broad daylight. 
He lived nearby to our health center and 
presented within 15 minutes of the bite. On 
arrival, his oxygen saturation was 99% in 
room air, pulse was 104/minute, and he was 
afebrile. Fang mark with minimal fresh 
bleeding and swelling was present at the site 
of the bite which later developed ecchymosis, 
Figure 1. Development of ptosis and slurring 
of speech was difficult to observe on 
presentation as the child was crying the whole 
time, leading to puffy eyes, Figure 2. There 
was no visible bleeding from other sites. 
Cardiopulmonary and central nervous system 
examination were unremarkable. Intravenous 
access (IV) was secured, the affected limb was 
immobilized and the child was kept under 




Figure 1. Case-1, bite site in a 9-year child 
showing fang mark with minimal bleeding 
 
After 30 minutes of arrival, the patient first 
developed ptosis followed by slurring of 
speech, difficulty in protruding the tongue 
and shortness of breath. His saturation 
dropped to 85% in room air. Oxygen was 
administered at 4 l/minute via nasal prongs 
and another IV access was secured. He 
received prophylactic subcutaneous 
adrenaline (1:1000) 0.12 ml stat. Ten vials of 
Anti Snake Venom Serum (ASVS) diluted in 
220 ml of normal saline was infused over 1-
hour. He also received intravenous atropine 
0.3 mg stat, intramuscular neostigmine 0.6 
mg stat, intravenous hydrocortisone 50 mg 
every 12 hours, and intramuscular tetanus 
toxoid 0.5 ml stat. Intravenous ondansetron 2 
mg stat was administered as the patient 
complained of nausea. He also received 
intravenous ceftriaxone 500 mg every 12 
hours and intravenous ranitidine 25 mg every 
12 hours.  
 
He was continuously monitored for signs of 
anaphylaxis. During the ASVS infusion, he 
developed profuse sweating and salivary 
secretions. He continued to maintain 
consciousness and obey instructions. He was 
able to spit out the secretions so suctioning 
was not necessary. Per rectal paracetamol, 
250 mg was given as the patient complained 
of pain at the bite site and body ache. Within 
an hour of starting ASVS, he gradually showed 
improvements - he was able to protrude his 
tongue, ptosis improved, and was weaned off 
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ASVS diluted in 500 ml of 5% dextrose was 
administered over 8 hours. He was 
catheterized and 300 ml of urine was 
collected which was normal in color. Two 
hours post-administration of ASVS, he showed 
no signs of neurotoxicity. An emergency 
laboratory facility was not available in the 
PHC. Lab reports obtained on the next day 
revealed hemoglobin 11 mg/dl, creatinine 0.7 
mg/dl, and normal urine analysis. He was 
discharged from PHC on day-2. The case was 
recorded as a presumed cobra bite in view of 
his symptoms, their progress, and prompt 
recovery. He was kept under alternate day 
follow-up for wound care. On his 4th follow-
up, the wound was gradually increasing in 
depth with areas of necrosis and hyperemia. 
The need for debridement was suspected and 
he was referred to a higher center for surgical 
consultation. 
   
      
 
Figure 2. Ptosis in case-1 (note the image is overlapped deliberately to minimize revealing the identity)  
Figure 3. Inability to protrude tongue and ptosis in case-2 
 
A 17-year-old with krait bite 
A 17-year-old male presented with the chief 
complaint of being bitten by a snake on his 
left thumb while collecting fodder in the 
forest. Within 30 minutes of the bite, he was 
brought to our center by his father on a 
motorbike from Basaha, a village 7.4 km 
away. He saw the snake but was unable to 
describe its identifying characteristics. On 
arrival, he looked comfortable and was 
maintaining oxygen saturation, pulse was 
110/min, respiratory rate was 14/min and 
blood pressure was 100/70 mmHg. A 
tourniquet had been applied at home, at base 
of the thumb. Fang marks were barely visible 
and there was no bleeding, ecchymosis, 
swelling, or pain at the site of the bite. 
Cardiopulmonary, gastrointestinal, and 
central nervous system examination were 
within normal limits. Intravenous access was 
secured, the affected limb was immobilized 
and the patient was kept under close 
monitoring with neurological examination 
done every 15 minutes. 
 
Repeated physical examinations did not yield 
any new findings during the first 3 hours of 
observation. The first symptoms the patient 
developed were blurring of vision and ptosis, 
Figure 3. After that, the decision to start ASVS 
was made and prophylactic subcutaneous 
adrenaline (1:1000) 0.25 ml stat was 
administered. He was given 10 vials of ASVS 
diluted in 400 ml of normal saline over 1 hour.  
He also received intravenous atropine 0.6 mg 
stat, intramuscular neostigmine 1.5 mg every 
30 mins, intravenous ondansetron 4 mg stat, 
intramuscular tetanus toxoid 1 ml stat, and 
intravenous hydrocortisone 200 mg 12 hourly. 
Ceftriaxone 1 g IV and ranitidine 50 mg IV 
were given every 12 hours. He was 
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Continuous examination revealed 
deterioration of his neurological status. He 
developed tachypnea, slurring of speech, 
inability to protrude tongue, and difficulty 
swallowing during 2 hours observation. 
Following progressive symptoms, additional 
dose of 5 vials ASVS diluted in 500 ml was 
given over another 1 hour. Intramuscular 
neostigmine was discontinued following no 
improvement in neurological symptoms. 
 
He did not develop signs of anaphylaxis during 
the ASVS infusion. Profuse sweating and 
salivary secretions were managed with 
suctioning and glycopyrrolate 0.5 mg. He 
remained conscious throughout.  
 
Improvement in symptoms did not start until 
2 hours after the administration of the second 
dose of ASVS. The blurring of vision was the 
first symptom to improve. His vitals stabilized 
and he gradually improved. His laboratory 
findings done on the second day were within 
normal limits. He was discharged on 3rd day of 
hospital admission and was called for follow-
up. Mild ptosis persisted up until 3rd day after 
discharge. The case was recorded as a 
presumed krait bite in view of his late onset of 
symptoms, absence of features of local 





Snakebite accounts for significant morbidity 
and mortality worldwide. Nepal has one of 
the highest snakebite fatality rates in South 
Asia.3 In Nepal, over 20,000 people are bitten 
by snakes each year and over 1000 die from 
envenomation as estimated by the World 
Health Organization.4 Most cases of 
snakebites are reported during summer and 
monsoon season, mostly from terai region of 
the country.1 Factors that increase snakebite 
incidence are plain terrain, long summer 
period with an average temperature of 36-
370C, long monsoon, and an agriculture-
dependent population. Disproportionately 
affecting poorer populations in rural areas 
seems to be a norm for snakebite worldwide.5  
 
 
At least 70 snake species are known to exist in 
Nepal.6,7 Most of the envenoming and deaths 
are caused by seven species: kraits (Bungarus 
caeruleus, B. walli, B. lividus, and B. niger), 
cobras (Naja naja and N. kaouthia) and viper 
(Daboia russelii).6,7 The clinical picture 
depends on the species, age of the snake, 
location, duration of the bite, and 
geographical location.8  
 
Management of snakebite is often focused on 
identifying species of snake, determination of 
toxicity, clinical stabilization, and use of 
appropriate antivenom.8,9 Envenomation by 
different families of venomous snakes often 
produces overlapping and nonspecific clinical 
symptoms which are frequently difficult to 
differentiate from anxiety due to the bite.8,9 
 
Nepal recently came up with its first protocol 
on snakebite management in 2019.10 The 
protocol divides venomous species found in 
Nepal into two groups 1) family Elapidae 
which consists of krait and cobra and 2) family 
Viperidae which includes vipers. The guideline 
proposes a syndromic approach to snakebite 
envenoming. The presenting symptoms are 
divided into 5 syndromes. The neurotoxic 
envenomation fall into Syndrome 1, 2, and 3. 
Neurotoxic presentations with local swelling 
are classified as syndrome 1 and are likely due 
to cobra bite while neurotoxic presentation 
with minimal local sign, abdominal pain, and 
nocturnal bites while sleeping on the ground 
is thought to be due to krait. If a neurotoxic 
presentation includes dark brown urine and 
muscle pain, it is classified as syndrome 3 and 
suggests B. niger krait bite.  
 
The onset of symptoms and complications 
happen promptly in cobra bite, sometimes as 
early as 30 minutes. Recovery after an 
appropriate treatment also follows a quick 
path because of the reversibility of the 
postsynaptic neurotoxicity of cobra venom. 
Krait bites, on the other hand, develop 
symptoms slowly and the rate at which 
recovery occurs is also slow. This slow nature 
of recovery is attributed to the fact that 
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presynaptic nerve terminal, repair of which is 
a time extensive process.10 
 
Snakebite is a time-sensitive issue. Rapid 
transportation of patients to nearby snakebite 
centers can be vital in determining 
management outcomes. An interventional 
study found a strong association between the 
use of a motorcycle, the quickest means of 
transport on the simple trails linking most 
villages in rural Nepal, with the survival of 
snakebite victim.11 
 
A complete blood count with platelet count, 
coagulation profile, measurement of fibrin 
degradation products, electrolytes, blood 
urea nitrogen, and serum creatinine, and 
urinalysis are recommended base-line 
laboratory studies. It is also recommended to 
repeat these after each infusion of 
antivenom.1 Beltar PHC probably represents 
many rural healthcare settings in Nepal and 
other developing countries, without the 
facilities to conduct many of these tests. 
Trained health personnel in the management 
of snake bites, availability of ASVS and 
emergency supplies are simple yet necessary 
lifesaving measures in such rural setups.   
 
Like most rural areas, there is an obvious 
shortage of anti-venoms in our setting. That 
means in terms of management while 
recognizing that antivenom is the mainstay of 
treatment, the importance of supportive 
therapy increases. Our patients were lucky in 
that we had a team of army trained in 
snakebites. We also happened to have an 
adequate supply of antivenom then, which is 
not a usual case. 
 
Despite the inadequacies, there are certain 
strengths of a PHC setting which makes it a 
crucial place for snakebite treatment. One of 
the major advantages of a rural PHC is its 
accessible location which can provide prompt 
supportive treatment in snakebite which is a 
very time-sensitive issue. Functioning as a 
bridge to higher centers, PHCs can aid in the 
management of complicated snakebite cases.  
 
The provision of manpower trained in the 
management of snakebite can help patients 
like that of ours. Most PHCs are looked after 
by medical officers. One way to ensure they 
have adequate knowledge and training in 
snakebite management is to expand the topic 
during the undergraduate medical school 
curriculum. At PAHS, snakebite is included as 
a clinical presentation under the topic Bites 
and Sting during Junior Clinical Rotation in 
Internal Medicine. However, this clinical 
presentation usually takes the form of a 
common lecture. While this touches on the 
topic of snakebite, it does not adequately 
prepare the graduates to deal with a case. 
Combined with the fact that we generally do 
not see cases of snakebites at Patan Hospital, 
the graduates do not get the first-hand 
experience in managing snakebite cases. 
Graduates of PAHS get posted in many 
snakebite prevalent settings. Hence, 
preparing them beforehand in the 
management of snakebite via curriculum 
modification, field visits to snakebite 
envenomation treatment centers, and 
training before placement can be beneficial. 
Institutional collaboration with the 
Epidemiology and Disease Control Division of 
Nepal for training the graduates can be a step 
towards universalization of management 
protocol in Nepal. 
 
A holistic approach to snakebite management 
include patient education, health personnel 
training (especially those going to rural 
regions in tropical countries), availability of 
life-saving measures at the treating center, 
emphasis on enlisting locally present snakes, 
maintaining a standard of care and quality 
and availability of antivenom. Use of 
tourniquet in snakebite is not 
recommended.10 However, our case-2 
presented with a tourniquet in place, a 
common first aid used by villagers.12 This 
demonstrates a need for community 
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Timely intervention and use of Anti Snake 
Venom Serum was successful in saving the 
lives of two case of snakebites at a primary 
health center in the peripheral terai region. 
Appropriate training of medical graduates 
before they are posted to snakebite prone 
areas and availability of basic facilities are 
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